| [1] | ESTEVES F, MEDRANO F J , DE ARMAS Y ,et al. Pneumocystis and pneumocystosis:first meeting of experts from Latin-American and Portuguese-speaking countries - a mini-review[J]. Expert Rev Anti Infect Ther ,2014 ,12 (5):545-548. DOI:10.1586/14787210.2014.894883 . | 
																													
																						| [2] | ESTEVES F, CALÉ S S , BADURA R ,et al. Diagnosis of pneumocystis pneumonia:evaluation of four serologic biomarkers[J]. Clin Microbiol Infect ,2015 ,21 (4):379.e1-379.10. DOI:10.1016/j.cmi.2014.11.025 . | 
																													
																						| [3] |  | 
																													
																						| [4] | SONG Y G, REN Y , WANG X W ,et al. Recent advances in the diagnosis of pneumocystis pneumonia[J]. Med Mycol J ,2016 ,57 (4):E111-116. DOI:10.3314/mmj.16-00019 . | 
																													
																						| [5] | WHITE P L, POSSO R B , GORTON R L ,et al. An evaluation of the performance of the Dynamiker® Fungus(1-3)-β-D-Glucan Assay to assist in the diagnosis of pneumocystis pneumonia[J]. Med Mycol ,2017 ,56 (6):778-781. DOI:10.1093/mmy/myx097 . | 
																													
																						| [6] | TASAKA S. Serum(1→3)β-d-glucan assay for discrimination between pneumocystis jirovecii pneumonia and colonization[J]. J Infect Chemother ,2014 ,20 (11):678-681. DOI:10.1016/j.jiac.2014.07.001 . | 
																													
																						| [7] | MIAO Q, MA Y Y , WANG Q Q ,et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice[J]. Clin Infect Dis ,2018 ,67 (suppl_2):S231-240. DOI:10.1093/cid/ciy693 . | 
																													
																						| [8] | WU X D, LI Y Y , ZHANG M ,et al. Etiology of severe community-acquired pneumonia in adults based on metagenomic next-generation sequencing:a prospective multicenter study[J]. Infect Dis Ther ,2020 ,9 (4):1003-1015. DOI:10.1007/s40121-020-00353-y . | 
																													
																						| [9] |  | 
																													
																						| [10] | DEURENBERG R H. Application of next generation sequencing in clinical microbiology and infection prevention[J]. J Biotechnol ,2017 ,243 :16-24. DOI:10.1016/j.jbiotec.2016.12.022 . | 
																													
																						| [11] |  | 
																													
																						| [12] | ROSSEN J W A, FRIEDRICH A W , MORAN-GILAD J ,et al. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology[J]. Clin Microbiol Infect ,2018 ,24 (4):355-360. DOI:10.1016/j.cmi.2017.11.001 . | 
																													
																						| [13] |  | 
																													
																						| [14] | MA L, CISSÉ O H , KOVACS J A . A molecular window into the biology and epidemiology of pneumocystis spp[J]. Clin Microbiol Rev ,2018 ,31 (3):e00009-00018. DOI:10.1128/CMR.00009-18 . | 
																													
																						| [15] | MORRIS A, NORRIS K A . Colonization by pneumocystis jirovecii and its role in disease[J]. Clin Microbiol Rev ,2012 ,25 (2):297-317. DOI:10.1128/CMR.00013-12 . | 
																													
																						| [16] | BABIC-ERCEG A, VILIBIC-CAVLEK T , ERCEG M ,et al. Prevalence of pneumocystis jirovecii pneumonia(2010-2013):the first Croatian report[J]. Acta Microbiol Immunol Hung ,2014 ,61 (2):181-188. DOI:10.1556/AMicr.61.2014.2.8 . | 
																													
																						| [17] | LOWE D M, RANGAKA M X , GORDON F ,et al. Pneumocystis jirovecii pneumonia in tropical and low and middle income countries:a systematic review and meta-regression[J]. PLoS One ,2013 ,8 (8):e69969. DOI:10.1371/journal.pone.0069969 . | 
																													
																						| [18] | SWAIN S D, SIEMSEN D W , PULLEN R R ,et al. CD4+  T cells and IFN-γ are required for the development of pneumocystis-associated pulmonary hypertension[J]. Am J Pathol ,2014 ,184 (2):483-493. DOI:10.1016/j.ajpath.2013.10.027 . | 
																													
																						| [19] | RIEBOLD D, ENOH D O , KINGE T N ,et al. Pneumocystis jirovecii colonisation in HIV-positive and HIV-negative subjects in Cameroon[J]. Trop Med Int Health ,2014 ,19 (6):643-655. DOI:10.1111/tmi.12299 . | 
																													
																						| [20] | LIU L, YUAN M J , SHI Y ,et al. Clinical performance of BAL metagenomic next-generation sequence and serum(1,3)-β-D-glucan for differential diagnosis of pneumocystis jirovecii pneumonia and pneumocystis jirovecii colonisation[J]. Front Cell Infect Microbiol ,2021 ,11 :784236. DOI:10.3389/fcimb.2021.784236 . | 
																													
																						| [21] | DAMIANI C, LE GAL S , DA COSTA C ,et al. Combined quantification of pulmonary pneumocystis jirovecii DNA and serum(1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and pneumocystis colonization[J]. J Clin Microbiol ,2013 ,51 (10):3380-3388. DOI:10.1128/JCM.01554-13 . | 
																													
																						| [22] | JIANG J, BAI L , YANG W ,et al. Metagenomic next-generation sequencing for the diagnosis of pneumocystis jirovecii pneumonia in non-HIV-infected patients:a retrospective study[J]. Infect Dis Ther ,2021 ,10 (3):1733-1745. DOI:10.1007/s40121-021-00482-y . | 
																													
																						| [23] | HELD J, KOCH M S , REISCHL U ,et al. Serum(1→3)-β-D-glucan measurement as an early indicator of pneumocystis jirovecii pneumonia and evaluation of its prognostic value[J]. Clin Microbiol Infect ,2011 ,17 (4):595-602. DOI:10.1111/j.1469-0691.2010.03318.x . |